---
title: "Organon (India) Ltd (INFARINDIA) — Share Price, Financials & Analysis"
symbol: "INFARINDIA"
company: "Organon (India) Ltd"
canonical: "https://tapetide.com/stocks/INFARINDIA"
generated_at: "2026-10-13T11:01:12.161Z"
---

# Organon (India) Ltd (INFARINDIA)

Canonical page: https://tapetide.com/stocks/INFARINDIA

## Company

- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 81.1%
- Company has been maintaining a healthy dividend payout of 238%

### Weaknesses

- The company has delivered a poor sales growth of -9.70% over past five years.
- Earnings include an other income of Rs.11.4 Cr.
- Working capital days have increased from 138 days to 254 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -96% | -25% | -11% |
| revenue growth | -29% | -17% | -10% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2011 | Dec 2012 | Mar 2014 15m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 151 | 159 | 168 | 186 | 216 | 283 | 223 | 227 | 183 | 129 |
| Expenses | 133 | 128 | 138 | 156 | 184 | 224 | 198 | 186 | 156 | 121 |
| Operating Profit | 18 | 32 | 29 | 30 | 32 | 59 | 25 | 41 | 27 | 9 |
| OPM % | 12 | 20 | 17 | 16 | 15 | 21 | 11 | 18 | 15 | 7 |
| Other Income | 9 | 10 | 6 | 0 | 0 | 0 | 19 | 108 | 388 | 11 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | 25 | 40 | 35 | 30 | 32 | 59 | 44 | 148 | 414 | 19 |
| Tax % | 41 | 35 | 32 | 34 | 33 | 35 | 33 | 28 | 24 | 36 |
| Net Profit | 15 | 26 | 23 | 19 | 21 | 38 | 29 | 107 | 313 | 12 |
| Dividend Payout % | 217 | 5 | 12 | 0 | 0 | 74 | 0 | 155 | 72 | 487 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 112 | 136 | 157 | 183 | 204 | 209 | 239 | 146 | 187 | 127 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 38 | 31 | 33 | 34 | 48 | 66 | 48 | 151 | 55 | 55 |
| Total Liabilities | 156 | 174 | 196 | 223 | 259 | 281 | 292 | 303 | 247 | 189 |
| Fixed Assets | 9 | 8 | 10 | 11 | 9 | 8 | 7 | 7 | 7 | 7 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investments | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 144 | 166 | 186 | 212 | 249 | 273 | 285 | 295 | 240 | 181 |
| Total Assets | 156 | 174 | 196 | 223 | 259 | 281 | 292 | 303 | 247 | 189 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 21 | 13 | -1 | 24 | 25 | 11 | 1 | 120 | 307 | -28 |
| Cash from Investing Activity | -8 | 6 | 8 | 7 | -72 | -20 | 75 | 18 | 18 | 11 |
| Cash from Financing Activity | -37 | -4 | -1 | 0 | -1 | 0 | -33 | -100 | -372 | -52 |
| Net Cash Flow | -25 | 15 | 6 | 30 | -48 | -9 | 43 | 38 | -47 | -69 |
| Free Cash Flow | 21 | 13 | -3 | 22 | 24 | 11 | 1 | 120 | 306 | -28 |
| CFO/OP | 194 | 75 | 42 | 120 | 125 | 52 | 74 | 390 | 1527 | -211 |

### Ratios

| Item | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 35 | 29 | 35 | 27 | 7 | 4 | 6 | 6 | 5 | 4 |
| Inventory Days | 119 | 165 | 256 | — | — | — | 131 | 118 | 87 | 122 |
| Days Payable | 143 | 129 | 117 | — | — | — | 111 | 107 | 121 | 238 |
| Cash Conversion Cycle | 11 | 65 | 174 | 27 | 7 | 4 | 26 | 17 | -29 | -112 |
| Working Capital Days | 121 | 144 | 159 | 102 | 202 | 176 | 161 | -10 | 170 | 254 |
| ROCE % | 19 | 31 | 23 | — | 16 | 28 | 19 | 75 | 241 | 12 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 24.68 | Sell |
| EMA (10) | 24.65 | Sell |
| SMA (20) | 25.05 | Sell |
| EMA (20) | 24.99 | Sell |
| SMA (50) | 25.52 | Sell |
| EMA (50) | 25.46 | Sell |
| SMA (100) | 26.16 | Sell |
| EMA (100) | 25.9 | Sell |
| SMA (200) | 26.52 | Sell |
| EMA (200) | 26.11 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.04 | Neutral |
| MACD (12,26,9) | -0.38 | Sell |
| Stochastic (14,3,3) | 20.9 | Neutral |
| ADX (14) | 42.78 | Buy |
| Williams %R (14) | -72.25 | Neutral |
| ATR (14) | 2.58 | High Volatility |
| ROC (12) | -4.3 | Sell |
| Stoch RSI (14) | 44.52 | Neutral |
| UO (7,14,28) | 35.47 | Neutral |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:01:12.161Z.